Fragile X Syndrome Research Today is a free monthly online journal that collates and summarizes the latest research about Fragile X Syndrome, including details on symptoms, treatment, heritability, diagnosis.

Volume 7 (2011), Issue 10 (October)

1. Behavioral phenotypes of genetic syndromes with intellectual disability: comparison of adaptive profiles.
   Psychiatry Res, 189(3): 440-5. [Abstract] [Full-text]
2. Bone health in primary ovarian insufficiency.
   Semin Reprod Med, 29(4): 317-27. [Abstract] [Full-text]
3. FMR1 and the continuum of primary ovarian insufficiency.
   Semin Reprod Med, 29(4): 299-307. [Abstract] [Full-text]
4. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.
   Acta Neuropathol, 122(4): 467-79. [Abstract] [Full-text]
5. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry.
   J Neurosci, 31(40): 14223-34. [Abstract] [Full-text]
6. Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation.
   Biol Psychiatry, 70(9): 852-8. [Abstract] [Full-text]
7. A novel assay for evaluating fragile X locus repeats.
   J Mol Diagn, 13(6): 614-20. [Abstract] [Full-text]
8. Vignettes: models in absentia.
   Results Probl Cell Differ, 54: 361-83. [Abstract] [Full-text]
9. The fragile X-associated tremor ataxia syndrome.
   Results Probl Cell Differ, 54: 337-57. [Abstract] [Full-text]
10. Fragile X syndrome and targeted treatment trials.
    Results Probl Cell Differ, 54: 297-335. [Abstract] [Full-text]
11. Fragile X syndrome: a psychiatric perspective.
    Results Probl Cell Differ, 54: 281-95. [Abstract] [Full-text]
12. Clinical aspects of the fragile X syndrome.
    Results Probl Cell Differ, 54: 273-9. [Abstract] [Full-text]
13. Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.
    Results Probl Cell Differ, 54: 255-69. [Abstract] [Full-text]
14. Fmr-1 as an offspring genetic and a maternal environmental factor in neurodevelopmental disease.
    Results Probl Cell Differ, 54: 243-53. [Abstract] [Full-text]
15. Taking STEPs forward to understand fragile X syndrome.
    Results Probl Cell Differ, 54: 223-41. [Abstract] [Full-text]
16. Neuroendocrine alterations in the fragile X mouse.
    Results Probl Cell Differ, 54: 201-21. [Abstract] [Full-text]
17. Exploring the zebra finch Taeniopygia guttata as a novel animal model for the speech-language deficit of fragile X syndrome.
    Results Probl Cell Differ, 54: 181-97. [Abstract] [Full-text]
18. Fragile X mental retardation protein and stem cells.
    Results Probl Cell Differ, 54: 157-64. [Abstract] [Full-text]
19. Molecular and genetic analysis of the Drosophila model of fragile X syndrome.
    Results Probl Cell Differ, 54: 119-56. [Abstract] [Full-text]
20. Behavior in a Drosophila model of fragile X.
    Results Probl Cell Differ, 54: 83-117. [Abstract] [Full-text]
21. The role of the postsynaptic density in the pathology of the fragile X syndrome.
    Results Probl Cell Differ, 54: 61-80. [Abstract] [Full-text]
22. Fragile X mental retardation protein (FMRP) and the spinal sensory system.
    Results Probl Cell Differ, 54: 41-59. [Abstract] [Full-text]
23. Neural stem cells.
    Results Probl Cell Differ, 54: 33-40. [Abstract] [Full-text]
24. Probing astrocyte function in fragile X syndrome.
    Results Probl Cell Differ, 54: 15-31. [Abstract] [Full-text]
25. Introduction: reminiscing on models and modeling.
    Results Probl Cell Differ, 54: 1-12. [Abstract] [Full-text]
26. Reliability of eye tracking and pupillometry measures in individuals with fragile X syndrome.
    J Autism Dev Disord, 41(11): 1515-22. [Abstract] [Full-text]
27. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
    J Pharmacol Exp Ther, 339(2): 474-86. [Abstract] [Full-text]
28. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    PLoS One, 6(10): e26203. [Abstract] [Full-text]
29. Sleep apnea in fragile X premutation carriers with and without FXTAS.
    Am J Med Genet B Neuropsychiatr Genet, 156(8): 923-8. [Abstract] [Full-text]

© 2005-2012 Fragile X Syndrome Research Today. All Rights Reserved.